Coupling reactions of hydralazine with amino acids and their adducts for antihypertensive activities

Journal of Heterocyclic Chemistry

Volumn 41, Issue 3, 2004, Pages 387-392

  Khattab, Sherine N ^a   El Massry, Abdel Moneim M ^a   El Faham, Ayman ^a   Bekhit, Adnan A ^b   Amer, Adel ^a  

^a Alexandria University Faculty Of Science   (Egypt)

^b Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,2,4 TRIAZOLO[3,4 A]PHTHALAZIN 3 YLETHYL)CARBAMIC ACID TERT BUTYL ESTER; 2 AMINO 3 (4 BENZYLOXYPHENYL)PROPIONIC ACID N' PHTHALAZIN 1 YLHYDRAZIDE; 2 BENZYLOXY 1 (1,2,4 TRIAZOLO[3,4 A]PHTHALAZIN 3 YLETHYL)CARBAMIC ACID TERT BUTYL ESTER; 2 METHYL 1 (1,2,4 TRIAZOLO[3,4 A]PHTHALAZIN 3 YLBUTYL)CARBAMIC ACID TERT BUTYL ESTER; 2 METHYL 1 (1,2,4 TRIAZOLO[3,4 A]PHTHALAZIN 3 YLPROPYL)CARBAMIC ACID TERT BUTYL ESTER; 2 METHYL 1 (1,2,4 TRIAZOLO[3,4 A]PHTHALAZIN 3 YLPROPYLAMINE; 4 AMINO 4 (1,2,4 TRIAZOLO[3,4 A]PHTHALAZIN 3 YLBUTYRIC ACID BENZYL ESTER; AMINO ACID; HYDRALAZINE; PHTHALAZINE DERIVATIVE; PRODRUG; UNCLASSIFIED DRUG; [2 (4 BENZYLOXYPHENYL) 1 (N' PHTHALAZIN 1 YLHYDRAZINOCARBONYL)ETHYL]CARBAMIC ACID TERT BUTYL ESTER;

ACYLATION; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG STRUCTURE; HYPERTENSION; INFRARED SPECTROSCOPY; NONHUMAN; PHARMACOPHORE; PROTON NUCLEAR MAGNETIC RESONANCE; RING CLOSING METATHESIS; STEREOSPECIFICITY; STRUCTURE ANALYSIS;

EID: 3042843875     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570410313     Document Type: Article

References (23)

1. Part 17 of the series, Synthetic Reactions and Structural Studies of Heterocycles Containing Nitrogens; for part 16 see: H. Zimmer, C. P. Librera, S. Hausner, J. Bauer and A. Amer, Molecules, 8, 735(2003).
2. B. L. Pegram, S. Ishize and E. D. Frohlich, Cadiovasc. Res., 45, 77 (2000).
3. G. R. Echevarria-Gorostidi, A. Basagoitia, E. Pizarro, R. Goldsmid, J. G. Santos Blanco and F. Garcia Blanco, Helv. Chim. Acta, 81, 837 (1998).
4. M. Sanchez-Salvatori, C. Rios and H. Vidrio, Cardiovascular Research, 37, 748 (1998).
5. S. Edwards and F. H. Marquardt, Hoppe-Seylers's Z. Physiol. Chem., 350, 85 (1969).
6. H. Zimmer, J. McManus, T Novinson, E. V. Hess, and A. H. Litwin, Arzneimittel-Forsch (Drug Research), 20, 1586 (1970).
7. H. Zimmer, J. Kokosa and D. A. Garteiz, Arzneimittel-Forschung (Drug Research), 23, 1028 (1973).
8. J. Druey and B. H. Ringier, Helv. Chim. Acta, 34, 195 (1951).
9. P. A. Reece, Med. Res. Rev., 1, 73 (1981).
10. K. T. Potts and Lovelette, J. Org. Chem., 34, 3221 (1969).
11. H. Zimmer, J. Kokosa and K. J. Shah, J. Org. Chem., 40, 2901 (1975).
12. A. Amer and H. Zimmer, J. Heterocyclic Chem., 18, 1625 (1981).
13. H. Zimmer, A. Amer and L. Baldwin, Pharmazie, 37, 451 (1982).
14. A. Amer and H. Zimmer, J. Heterocyclic Chem., 20, 1231 (1983).
15. A. Amer and H. Zimmer, Heterocycles, 26,1177 (1987).
16. A. Amer, K. Weisz and H. Zimmer, Heterocycles, 26, 1853 (1987).
17. A. Amer, A. M. El-Massry, S. El-Sadany and H. Zimmer, J. Chem. Research (S), 298, (1988).
18. H. Zimmer, A. R. Safwat, D. Ho, A. Amer and M. Badawi, J. Org. Chem., 60, 1908 (1995).
19. D. C. Young, Computational Chemistry, John Wiley & Sons, New York, NY, 2001, pp 37, pp 342.
20. M. Verma, M. Tripathi, A. K. Saxena and K. Shanker, Eur. J. Med. Chem., 29, 941 (1994).
21. J. T. Litchfield and F. Wilcoxon, J. Pharmacol. Exp. Ther., 96, 99 (1949).
22. A. A. Bekhit, and H. T. Y. Fahmy, Archiv Pharm. Pharm. Med. Chem., 336, 111 (2003).
23. M. M. El-Mas and A. A. Abdel-Rahman, J. Pharmacol. Exp. Ther., 266, 602 (1993).